KRAS and familial pancreatic carcinoma: In the current research situation, it is known that the high mutation frequency of pancreatic cancer driving genes, such as KRAS. KRAS mutations were detected in plasma ctDNA of patients with pancreatic cancer as early as 1994 (5), and now KRAS mutations are widely used in diagnosis and monitoring.